Table 3.
Characteristics of the population from all hospitals by financial year 08/09–16/17 – patients with an ISS ≥ 9.
| Financial year |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2008/09 | 2009/10 | 2010/11 | 2011/12 | 2012/13 | 2013/14 | 2014/15 | 2015/16 | 2016/17 | Total | |
| Number of hospitals submitting to TARN | 91 | 120 | 149 | 164 | 175 | 176 | 173 | 171 | 169 | 189 |
| Number of TARN cases that year | 8903 | 12,123 | 17,956 | 23,211 | 28,239 | 33,647 | 37,725 | 42,371 | 44,059 | 248,234 |
| Age, median (IQR) | 47 (26–63.8) | 51 (29–67) | 52.6 (30–71) | 55 (32–74) | 58 (36–77) | 60 (38–79) | 62 (42–81) | 63 (42.9–81.6) | 64.5 (44–82) | 59.6 (38–79) |
| Age > 64, n (%) | 2041 (22.9%) | 3288 (27.1%) | 5400 (30.1%) | 7752 (33.4%) | 10,725 (38%) | 14,005 (41.6%) | 17,170 (45.5%) | 20,147 (47.5%) | 21,688 (49.2%) | 102,216 (41.2%) |
| Male, n (%) | 5798 (65.1%) | 7772 (64.1%) | 11,166 (62.2%) | 14,217 (61.3%) | 16,457 (58.3%) | 19,323 (57.4%) | 21,094 (55.9%) | 23,775 (56.1%) | 24,225 (55%) | 143,827 (57.9%) |
| ISS, median (IQR) | 10 (9–20) | 12 (9–20) | 11 (9–20) | 10 (9–20) | 10 (9–20) | 10 (9–20) | 10 (9–20) | 10 (9–20) | 12 (9–20) | 10 (9–20) |
| First hospital GCS, median (IQR) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (14–15) | 15 (15–15) | 15 (15–15) | 15 (15–15) | 15 (15–15) | 15 (15–15) | 15 (15–15) |
| RTC, n (%) | 2825 (31.7%) | 3438 (28.4%) | 4568 (25.4%) | 5782 (24.9%) | 6239 (22.1%) | 7510 (22.3%) | 8012 (21.2%) | 8688 (20.5%) | 8683 (19.7%) | 55,745 (22.5%) |
| High fall, n (%) | 1354 (15.2%) | 1829 (15.1%) | 2649 (14.8%) | 3191 (13.7%) | 3668 (13%) | 4462 (13.3%) | 4674 (12.4%) | 4917 (11.6%) | 5098 (11.6%) | 31,842 (12.8%) |
| Low fall, n (%) | 3279 (36.8%) | 4948 (40.8%) | 7984 (44.5%) | 11,097 (47.8%) | 14,973 (53%) | 17,986 (53.5%) | 21,271 (56.4%) | 24,679 (58.2%) | 25,869 (58.7%) | 132,086 (53.2%) |
| Other, n (%) | 676 (7.6%) | 850 (7%) | 1258 (7%) | 1536 (6.6%) | 1694 (6%) | 1881 (5.6%) | 1902 (5%) | 2011 (4.7%) | 2080 (4.7%) | 13,888 (5.6%) |
| Assault, n (%) | 769 (8.6%) | 1058 (8.7%) | 1497 (8.3%) | 1605 (6.9%) | 1665 (5.9%) | 1808 (5.4%) | 1866 (4.9%) | 2076 (4.9%) | 2329 (5.3%) | 14,673 (5.9%) |
| Penetrating, n (%) | 540 (6.1%) | 689 (5.7%) | 870 (4.8%) | 1056 (4.5%) | 989 (3.5%) | 964 (2.9%) | 975 (2.6%) | 1199 (2.8%) | 1330 (3%) | 8612 (3.5%) |
| TBI, n (%) | 2658 (30.6%) | 3713 (31.5%) | 5533 (32.3%) | 6707 (30.5%) | 7738 (29.3%) | 9214 (29.6%) | 10,272 (29.5%) | 12,048 (30.8%) | 12,753 (31.3%) | 70,636 (30.5%) |
| Extracranial, n (%) | 6527 (75.1%) | 8761 (74.3%) | 12,495 (73%) | 16,321 (74.3%) | 19,730 (74.8%) | 23,199 (74.5%) | 26,030 (74.7%) | 28,753 (73.6%) | 29,733 (73%) | 171,549 (74%) |
| Comorbidity present, n (%) | 3603 (40.5%) | 5438 (44.9%) | 8838 (49.2%) | 12,510 (53.9%) | 16,042 (56.8%) | 20,121 (59.8%) | 24,313 (64.4%) | 29,367 (69.3%) | 30,980 (70.3%) | 151,212 (60.9%) |